Delaware Code § 18-3555B

Coverage of drugs approved for treatment of certain cancers [For application of this section, see 81
Open in Lexace · Ask the AI about this section
Del. Laws, c. 180, §§ 3 and 4; 84 Del. Laws, c. 338, 3].
(a) No group or blanket policy or contract of health insurance, or certificate issued thereunder, which is delivered, issued for delivery,
renewed, modified, altered, or amended in this State that directly or indirectly covers the treatment of cancer shall limit or exclude coverage
for a drug approved by the United States Food and Drug Administration by mandating that the insured shall first be required to fail to
successfully respond to a different drug or drugs or prove a history of failure of a different drug or drugs; provided, however that the
use of such drug or drugs is consistent with best practices for the treatment of stage 4 advanced, metastatic cancer or in the case of other
cancers, the use of the drug is supported by national clinical guidelines, national standards of care, or for the treatment of the cancer, or
in the case of targeted therapy, the target at issue.
(b) No group or blanket policy or contract of health insurance, or certificate issued thereunder, which is delivered, issued for delivery,
renewed, modified, altered, or amended in this State that directly or indirectly cover the associated conditions of metastatic cancer shall
limit or exclude coverage for drugs approved by the United States Food and Drug Administration by mandating that the insured shall first
be required to fail to successfully respond to a different drug or drugs or prove a history of failure of a different drug or drugs; provided,
however that the use of such drug is consistent with best practices for the treatment of the associated conditions of metastatic cancer and
is supported by national clinical guidelines, national standards of care, or peer reviewed medical literature.
(c) For purposes of this section, "associated conditions" mean the symptoms or side effects associated with metastatic cancer or its
treatment and which, in the judgment of the health-care practitioner, further jeopardizes the health of a patient if left untreated.

‹ Prev All Delaware sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.